aDepartment of Otolaryngology - Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA bInstitute for Translational Epidemiology, Icahn School of Medicine at Mount ...
Growth was driven by the combination of an increase in the number of nights sold (+4.2%) and higher average letting rates (+1.5%), benefiting both: - the French domains: +8.8% (with strong ...
Long-Term Efficacy and Safety of Taletrectinib in Patients With ROS1+ Non–Small Cell Lung Cancer: Results From the Phase II TRUST-I Study Patient subtypes included in the regorafenib arm of GBM AGILE ...
Isabel O’Brien is an experienced business journalist who specializes in private equity, infrastructure, and financial misconduct. Westend61 / Getty Images A $1.5 million retirement fund can fall short ...
CHICAGO, Aug. 19, 2025 (GLOBE NEWSWIRE) -- COUR Pharma, a clinical-stage biotechnology company developing first-in-class, disease-modifying therapies to treat autoimmune diseases, today announced that ...
At current emission rates, we're just over three years away from blowing through the remaining carbon budget to limit warming to 1.5°C. This new international study paints a stark picture: the pace of ...
WASHINGTON, April 22 (Reuters) - The International Monetary Fund on Tuesday slashed its growth forecasts for the United States, China and most countries, citing the impact of U.S. tariffs now at ...
Earth is crossing the threshold of 1.5°C of global warming, according to two major global studies which together suggest the planet’s climate has likely entered a frightening new phase. Under the ...
CHICAGO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- COUR Pharmaceuticals, a clinical-stage biotechnology company developing first-in-class, disease-modifying therapies designed to induce antigen-specific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results